292 related articles for article (PubMed ID: 35372042)
1. Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.
Li Y; Lin M; Wang S; Cao B; Li C; Li G
Front Oncol; 2022; 12():842960. PubMed ID: 35372042
[TBL] [Abstract][Full Text] [Related]
2. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis.
Larionova I; Kazakova E; Gerashchenko T; Kzhyshkowska J
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209679
[TBL] [Abstract][Full Text] [Related]
3. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
4. Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.
Ayoub NM; Jaradat SK; Al-Shami KM; Alkhalifa AE
Front Pharmacol; 2022; 13():838133. PubMed ID: 35281942
[TBL] [Abstract][Full Text] [Related]
5. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
6. [Development of novel angiogenesis inhibitors targeting VEGF (vascular endothelial growth factor) for cancer chemotherapy].
Kakeya H; Osada H
Nihon Rinsho; 2004 Jul; 62(7):1264-70. PubMed ID: 15283142
[TBL] [Abstract][Full Text] [Related]
7. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential.
Lahooti B; Poudel S; Mikelis CM; Mattheolabakis G
Front Oncol; 2021; 11():705634. PubMed ID: 34956857
[TBL] [Abstract][Full Text] [Related]
8. Emerging angiogenesis inhibitors for non-small cell lung cancer.
Malapelle U; Rossi A
Expert Opin Emerg Drugs; 2019 Jun; 24(2):71-81. PubMed ID: 31092048
[No Abstract] [Full Text] [Related]
9. Tumor-induced neoangiogenesis and receptor tyrosine kinases - Mechanisms and strategies for acquired resistance.
Yunus M; Jansson PJ; Kovacevic Z; Kalinowski DS; Richardson DR
Biochim Biophys Acta Gen Subj; 2019 Jul; 1863(7):1217-1225. PubMed ID: 31029846
[TBL] [Abstract][Full Text] [Related]
10. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic application of anti-angiogenic nanomaterials in cancers.
Mukherjee S; Patra CR
Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
[TBL] [Abstract][Full Text] [Related]
12. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
13. Dll4-Notch signaling in regulation of tumor angiogenesis.
Liu Z; Fan F; Wang A; Zheng S; Lu Y
J Cancer Res Clin Oncol; 2014 Apr; 140(4):525-36. PubMed ID: 24114288
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Cancer Biology, Pathophysiological Development and It's Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy.
Al-Ostoot FH; Salah S; Khanum SA
Cancer Invest; 2024 Jun; ():1-46. PubMed ID: 38874308
[TBL] [Abstract][Full Text] [Related]
16. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
17. Targeting Angiogenesis in Cancer Treatments: Where do we Stand?
Petrovic N
J Pharm Pharm Sci; 2016; 19(2):226-38. PubMed ID: 27518172
[TBL] [Abstract][Full Text] [Related]
18. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
19. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic therapy in breast cancer.
Atiqur Rahman M; Toi M
Biomed Pharmacother; 2003 Dec; 57(10):463-70. PubMed ID: 14637390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
